The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma
Status:
Enrolling by invitation
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
Spinal hemangioma is one of the most common benign vertebral tumours. Being mostly
asymptomatic, it is still associated with a pain syndrome especially if encroaches into the
neural canal.
This study is organised to evaluate the efficacy and safety of β-blockers drugs in adults
with spinal hemangioma.